Embed Size (px)
DESCRIPTION
This report analyzes the worldwide markets for Molecular Diagnostics in US$ Thousands by the following Applications: Infectious Disease Testing, Blood Screening, Cancer Screening, and Other Applications. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 165 companies including many key and niche players such as - Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Cepheid, CytoCore Inc. Molecular Diagnostics, Infectious Disease Testing, Blood Screening, Cancer Screening, Pharmacogenomics, Tissue Typing, Prenatal Testing, Prenatal Genetic Testing, Inherited Disease Testing, Invitro Diagnostics, Polymerase Chain Reaction, Personalized Medicine, Companion Diagnostics, PCR Market, Quantitative Real-Time PCR, Quantitative Real-Time RT-PCR, Digital PCR, Signal Amplification Technologies, Molecular Biomarkers, DNA Probes, Nucleic Acid Amplification, DNA Sequencing, Gene Detection, DNA Chips, RNA Diagnostics, Fluorescent In-Situ Hybridization, DNA Biochips/Microarrays, Proteomic Technologies
Citation preview
“Increasing Molecular Level Understanding of Disease State & Metabolism Drives the Molecular Diagnostics Market”
“Increasing Molecular Level Understanding of Disease State & Metabolism Drives the Molecular Diagnostics Market”
© Global Industry Analysts, Inc., 6150 Hellyer Ave., San Jose, CA 95138, USA, Phone: 408-528-9966. All Rights Reserved
For more details
July 2014 ReleaseJuly 2014 Release
© Global Industry Analysts, Inc., 6150 Hellyer Ave., San Jose, CA 95138, USA, Phone: 408-528-9966. All Rights Reserved
Global market for Molecular Diagnostics is projected to reach US$10.7 billion by 2020, driven by aging population, increasing prevalence of chronic and life-threatening diseases, growing need for better disease diagnostics, and advancements in proteomics and genomics. Genomics and proteomics coupled with Nanobiotechnology represent major technology drivers in the market. Countries such as China, India, Singapore and Brazil present wealth of opportunities encouraged by improving healthcare infrastructure, growing middle class population, high prevalence of chronic diseases, prospering economies, and increasing healthcare needs of an aging population.
• Abbott Laboratories
• Becton
• Dickinson and Company
• bioMérieux SA
• F. Hoffmann-La Roche Ltd.
• GE Healthcare
• Quest Diagnostics, Inc.
• Siemens AG
• Thermo Fisher Scientific
Major Players…US$10.7
Billion
2014 2015 2016 2017 2018 202020192013
© Global Industry Analysts, Inc., 6150 Hellyer Ave., San Jose, CA 95138, USA, Phone: 408-528-9966. All Rights Reserved
• Regulatory Efforts to Address Logistical
& Ethical Barriers to Benefit Market
Growth
• Rise in HPV, Hepatitis C & AIDS: A Key
Driver
• Focus on Early Diagnosis Spurs
Diagnostic Test Volumes
• Growing Interest in Personalized
Medicine to Benefit the Market for
Molecular Diagnostics
• Next-Generation Sequencing
Technologies Lend Traction to Growth
• Reimbursement Issues: A Key
Challenge
Snapshot Summary of Trends & Drivers
• The United States represents the
largest market worldwide. Asia-Pacific
ranks as the fastest growing market
with a CAGR of 10.7% over the
analysis period.
USA
© Global Industry Analysts, Inc., 6150 Hellyer Ave., San Jose, CA 95138, USA, Phone: 408-528-9966. All Rights Reserved
GIA’s Actionable Research Insights
Market Analytics Market Profiling Competitive Intelligence
• Estimates and Forecasts for
2013-2020
• Geographic Regions Analyzed
– The United States, Canada,
Japan, Europe (France,
Germany, Italy, UK, Spain,
Russia and Rest of Europe),
Asia-Pacific (China, and Rest
of Asia-Pacific), Latin America
and Rest of World.
• End-Use Applications
Analyzed - Infectious Disease
Testing, Blood Screening,
Cancer Screening and Others.
• Market Trends & Issues
• Growth Drivers & Enablers
• Growth Inhibitors
• Opportunities and Challenges
• Recent Industry Activity
• Product Innovations & Trends
• Market Analyses, Facts,
Figures & Forecasts
• Coverage of Major & Niche
Players
• Comprehensive Geographic
Coverage
• End-Use Market Analysis
• 165 major and niche players covered
To browse full report table of contents, please
© Global Industry Analysts, Inc., 6150 Hellyer Ave., San Jose, CA 95138, USA, Phone: 408-528-9966. All Rights Reserved
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes 1500+ full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc.Telephone: 408-528-9966Fax: 408-528-9977 Email: [email protected] Site: http://www.strategyr.com/
© Global Industry Analysts, Inc., 6150 Hellyer Ave., San Jose, CA 95138, USA, Phone: 408-528-9966. All Rights Reserved
The research report titled “Molecular Diagnostics: A Global Strategic Business Report” published by
Global Industry Analysts, Inc., is now available for purchase online. To view report excerpts and the
full table of contents (TOC) and to sign up for a comprehensive complimentary review of our research
program including details on methodology, secondary and primary sources and summary of research
findings, please visit – http://www.strategyr.com/Molecular_Diagnostics_Market_Report.asp
